• English
  • Deutsch
  • Log In
    Password Login
    Research Outputs
    Fundings & Projects
    Researchers
    Institutes
    Statistics
Repository logo
Fraunhofer-Gesellschaft
  1. Home
  2. Fraunhofer-Gesellschaft
  3. Scopus
  4. Modern venomics - Current insights, novel methods, and future perspectives in biological and applied animal venom research
 
  • Details
  • Full
Options
2022
Review
Title

Modern venomics - Current insights, novel methods, and future perspectives in biological and applied animal venom research

Abstract
Venoms have evolved >100 times in all major animal groups, and their components, known as toxins, have been fine-tuned over millions of years into highly effective biochemical weapons. There are many outstanding questions on the evolution of toxin arsenals, such as how venom genes originate, how venom contributes to the fitness of venomous species, and which modifications at the genomic, transcriptomic, and protein level drive their evolution. These questions have received particularly little attention outside of snakes, cone snails, spiders, and scorpions. Venom compounds have further become a source of inspiration for translational research using their diverse bioactivities for various applications. We highlight here recent advances and new strategies in modern venomics and discuss how recent technological innovations and multi-omic methods dramatically improve research on venomous animals. The study of genomes and their modifications through CRISPR and knockdown technologies will increase our understanding of how toxins evolve and which functions they have in the different ontogenetic stages during the development of venomous animals. Mass spectrometry imaging combined with spatial transcriptomics, in situ hybridization techniques, and modern computer tomography gives us further insights into the spatial distribution of toxins in the venom system and the function of the venom apparatus. All these evolutionary and biological insights contribute to more efficiently identify venom compounds, which can then be synthesized or produced in adapted expression systems to test their bioactivity. Finally, we critically discuss recent agrochemical, pharmaceutical, therapeutic, and diagnostic (so-called translational) aspects of venoms from which humans benefit.
Author(s)
Reumont, Björn Marcus von
Anderluh, Gregor
Antunes, Agostinho
Aivazyan, Naira M.
Beis, Dimitris
Çalışkan, Figen
Crnković, Ana
Damm, Maik
Dutertre, Sébastien
Ellgaard, Lars
Gajski, Goran
German, Hannah
Halassy, Beata
Hempel, Benjamin-Florian
Hucho, Tim B.
İğci̇, Naşit
Ikonomopoulou, Maria P.
Karbat, Izhar
Klapa, María I.
Koludarov, Ivan P.
Kool, Jeroen
Lüddecke, Tim
Fraunhofer-Institut für Molekularbiologie und Angewandte Oekologie IME  
Ben Mansour, Riadh
Vittoria Modica, Maria
Moran, Yehu
Nalbantsoy, Ayse
Ibáñez, María Eugenia Pachón
Panagiotopoulos, Alexios
Reuveny, Eitan
Céspedes, Javier Sánchez
Sombke, Andy
Surm, Joachim M.
Undheim, Eivind Andreas Baste
Verdes, Aida
Zancolli, Giulia
Journal
GigaScience  
DOI
10.1093/gigascience/giac048
Language
English
Fraunhofer-Institut für Molekularbiologie und Angewandte Oekologie IME  
Keyword(s)
  • antivenom

  • bioassays

  • envenomation

  • evolution

  • genomics

  • modern venomics

  • spatial -omics

  • toxin production

  • translational research

  • venom

  • Cookie settings
  • Imprint
  • Privacy policy
  • Api
  • Contact
© 2024